Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: A look at CIRM, Catapult and CCRM

Back in November 2020, California voters approved Proposition 14. That means US$5.5B is being directed to the California Institute for Regenerative Medicine (CIRM) to support promising cell and gene therapy research so the organization can continue the important work...

Right Turn: Careers in advanced manufacturing

The incredible, non-stop growth of the global cell and gene therapy market – valued at ~$12 billion by 2025 – means that talent is in high demand. (That estimate does not include tissue engineering, but it still seems low.) While seasoned professionals and those with...

Rebuilding the Canadian biomanufacturing sector

  From the H1N1 pandemic of 2009, Canada recognized it was not ready for a pandemic. “What we were not prepared for was for the pandemic to occur when it did,” said an interviewee at a panel review of Canada’s response to the 2009 H1N1 pandemic. “So, it...

Harnessing the liver’s power to regenerate

This article was authored by Julie Crljen, Coordinator, Communications and Outreach at Medicine by Design, a strategic initiative that harnesses the expertise at the University of Toronto and its affiliated hospitals to undertake transformative research in...